These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 7010518)
21. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314 [TBL] [Abstract][Full Text] [Related]
22. IgG 1 subclass specificity for IgG rheumatoid factors in patients with rheumatoid arthritis. Miyata M; Sato Y; Kasukawa R J Rheumatol; 1999 Jul; 26(7):1436-8. PubMed ID: 10405926 [TBL] [Abstract][Full Text] [Related]
23. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester. Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996 [TBL] [Abstract][Full Text] [Related]
24. [Diagnostic performance of anti-cyclic citrullinated antibodies and IgM rheumatoid factor in rheumatoid arthritis]. Lemos A; Ramos MP; Furtado MJ; Carvalho C; Santos MJ; Silva JC; Ventura H Acta Reumatol Port; 2007; 32(4):345-9. PubMed ID: 18159201 [TBL] [Abstract][Full Text] [Related]
25. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester. Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254 [TBL] [Abstract][Full Text] [Related]
26. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078 [TBL] [Abstract][Full Text] [Related]
27. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells. Mathsson L; Lampa J; Mullazehi M; Rönnelid J Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263 [TBL] [Abstract][Full Text] [Related]
28. Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clinical significance. Gupta B; Raghav SK; Agrawal C; Chaturvedi VP; Das RH; Das HR J Autoimmun; 2006 Sep; 27(2):125-33. PubMed ID: 16904869 [TBL] [Abstract][Full Text] [Related]
29. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders. Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033 [TBL] [Abstract][Full Text] [Related]
30. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Vallbracht I; Rieber J; Oppermann M; Förger F; Siebert U; Helmke K Ann Rheum Dis; 2004 Sep; 63(9):1079-84. PubMed ID: 15308516 [TBL] [Abstract][Full Text] [Related]
32. Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis. Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K Br J Dermatol; 2004 Oct; 151(4):803-8. PubMed ID: 15491420 [TBL] [Abstract][Full Text] [Related]
33. IgM rheumatoid factors react with human class I HLA molecules. Williams RC; Malone CC; Kao KJ J Immunol; 1996 Feb; 156(4):1684-94. PubMed ID: 8568276 [TBL] [Abstract][Full Text] [Related]
34. [Topics on immunological tests for rheumatoid arthritis]. Kumagai S; Nishimura K; Hayashi N Rinsho Byori; 2004 Oct; 52(10):836-43. PubMed ID: 15624500 [TBL] [Abstract][Full Text] [Related]
35. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467 [TBL] [Abstract][Full Text] [Related]
36. [Comparison of rheumatoid test procedures--value and critical interpretation of sensitivity and specificity and their effect on pre-test and post-test probability]. Aupperle KR; Alsalameh S; Stock KP; Burmester GR; Kalden JR Z Rheumatol; 1996; 55(3):158-67. PubMed ID: 8768145 [TBL] [Abstract][Full Text] [Related]
38. [IgG RF analysis of supernatant of cultured synovia in patients with rheumatoid arthritis]. Yu M; Zhang C; Shi L; Shan X Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):151-4. PubMed ID: 7656398 [TBL] [Abstract][Full Text] [Related]
39. Serum markers of rheumatoid arthritis in visceral leishmaniasis: rheumatoid factor and anti-cyclic citrullinated peptide antibody. Atta AM; Carvalho EM; Jerônimo SM; Sousa Atta ML J Autoimmun; 2007 Feb; 28(1):55-8. PubMed ID: 17257811 [TBL] [Abstract][Full Text] [Related]
40. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Nielen MM; van Schaardenburg D; Reesink HW; van de Stadt RJ; van der Horst-Bruinsma IE; de Koning MH; Habibuw MR; Vandenbroucke JP; Dijkmans BA Arthritis Rheum; 2004 Feb; 50(2):380-6. PubMed ID: 14872479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]